+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Nucleic Acid Isolation & Purification Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 188 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5146092
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The nucleic acid isolation and purification market is evolving rapidly as laboratories and organizations prioritize automation, digitalization, and sustainable practices to address heightened research and clinical demands. Senior decision-makers benefit from targeted intelligence that enhances procurement agility, R&D effectiveness, and operational competitiveness in this dynamic sector.

Market Snapshot: Nucleic Acid Isolation & Purification Market Growth

The global nucleic acid isolation and purification market is experiencing notable expansion, valued at USD 7.58 billion in 2024, advancing to USD 8.32 billion in 2025, and projected to reach USD 16.16 billion by 2032, representing a CAGR of 9.92%. Key forces fueling this growth include wider adoption of automated technologies, increasing demand for clinical diagnostic applications, and greater financial commitment to molecular research. As digitalization streamlines laboratory operations, providers can consistently offer precise and timely genomic analysis across diverse research and clinical settings worldwide.

Scope & Segmentation: Comprehensive Market Coverage

This report provides senior leadership with a clear understanding of the nucleic acid isolation and purification market by segmenting pivotal categories, core technologies, target applications, and global geographies. The survey supports strategic benchmarking and planning for procurement leads, R&D directors, and commercial strategists responding to evolving end-user needs and regulatory requirements.

  • Product Types: Instruments, automated workstations, purification instruments, kits and reagents, magnetic bead kits, spin column kits, and services shape procurement decisions and upgrading lab workflows.
  • Technology: Column approaches, filter-based methods, magnetic bead systems, and precipitation techniques reflect the diverse technological choices available for optimizing nucleic acid extraction, impacting cost, purity, and scalability.
  • Sample Sources: Blood samples, cell preparations, and tissue specimens serve both clinical and research operations, allowing organizations to tailor methods based on sample complexity and use case.
  • Applications: Diagnostics across oncology, genetic disorders, and infectious diseases; gene expression analysis; targeted, transcriptome, and whole genome sequencing; PCR and RT-PCR applications drive the need for high-quality extraction processes.
  • End Users: Academic and research institutes, clinical diagnostics laboratories, contract research organizations, pharmaceutical and biotechnology companies are stakeholders in discovery, validation, and commercialization phases.
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, UAE, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan) each presenting unique market dynamics and growth prospects.
  • Companies Analyzed: Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Merck KGaA, Perkin Elmer Inc., Promega Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Norgen Biotec Corp., Genaxxon bioscience GmbH, Danaher Corporation, F. Hoffmann-La Roche Ltd.

Key Takeaways: Strategic Insights for Decision-Makers

  • Automation and digital platforms support increased throughput and improve standardization, helping labs meet strict accuracy and reproducibility requirements across diverse environments.
  • Hybrid systems combining spin column and magnetic bead technologies deliver flexible, scalable solutions adaptable for emerging research applications and varied operational scales.
  • Leading companies develop advanced chemistries and integrate real-time quality control and tailored buffer systems, enhancing reliability for downstream clinical and academic workflows.
  • Sustainability initiatives, including eco-friendly reagents and recyclable consumables, are becoming significant factors in procurement, supporting supplier differentiation and compliance with environmental goals.
  • Regional factors, such as supply chain localization in Asia-Pacific and sustained innovation investment in North America, drive the need for workflow customization and responsive supply networks.

Tariff Impact on United States Market

Recent tariff adjustments on laboratory consumables and instruments have increased cost pressures in the U.S. nucleic acid isolation and purification sector. Organizations respond by expanding supplier networks, sourcing from regional manufacturers, and enhancing inventory management to maintain cost efficiency and safeguard operational continuity.

Methodology & Data Sources

This analysis employs a mixed-methods approach, uniting secondary research from peer-reviewed literature, regulatory filings, and company financials with direct interviews of industry executives. Reliability is reinforced through data triangulation and scenario mapping, ensuring senior leaders receive actionable, validated intelligence.

Nucleic Acid Isolation & Purification Market: Why This Report Matters

  • Enables procurement and R&D leadership to make informed investment decisions through actionable segmentation and strategic recommendations tailored to market realities.
  • Facilitates benchmarking of technology adoption, supply chain models, and sustainability priorities among global and regional players.
  • Supports alignment with regulations and evolving operational requirements to drive scalability and improve long-term reliability in laboratory processes.

Conclusion

This report equips senior decision-makers with vital insights into automation, sustainability, and regulatory shifts, enabling organizations to capture new opportunities and manage challenges within a complex global market environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of magnetic bead technology in fully automated sample preparation platforms for high-throughput diagnostics
5.2. Adoption of microfluidic chip systems enabling rapid point-of-care nucleic acid extraction in decentralized settings
5.3. Development of ambient temperature stable reagents reducing cold chain dependency for field-based genetic testing workflows
5.4. Emergence of single-cell RNA isolation kits optimized for ultra-low input and high transcriptome coverage
5.5. Expansion of direct lysis methodologies streamlining viral RNA extraction for next-day infectious disease surveillance
5.6. Implementation of AI-driven protocol optimizations improving yield and purity in genomic sample purification pipelines
5.7. Scale-up of 96- and 384-well plate-based purification kits supporting pandemic-scale testing demands in clinical labs
5.8. Integration of green chemistry approaches in lysis buffers minimizing hazardous waste generation in molecular biology
5.9. Customization of automated nucleic acid extraction workstations for multiplexed plant pathogen detection in agriculture
5.10. Advancements in nanopore-friendly extraction methods enhancing long-read sequencing quality for structural variant analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Nucleic Acid Isolation & Purification Market, by Product Type
8.1. Instruments
8.1.1. Automated Workstations
8.1.2. Purification Instruments
8.2. Kits & Reagents
8.2.1. Magnetic Bead Kits
8.2.2. Spin Column Kits
8.3. Services
9. Nucleic Acid Isolation & Purification Market, by Technology
9.1. Column
9.2. Filter
9.3. Magnetic Bead
9.4. Precipitation
10. Nucleic Acid Isolation & Purification Market, by Sample Type
10.1. Blood
10.2. Cells
10.3. Tissue
11. Nucleic Acid Isolation & Purification Market, by Application
11.1. Diagnostics
11.1.1. Cancer Diagnostics
11.1.2. Genetic Disorder Testing
11.1.3. Infectious Disease Diagnostics
11.2. Gene Expression Analysis
11.3. Next Generation Sequencing
11.3.1. Targeted Sequencing
11.3.2. Transcriptome Sequencing
11.3.3. Whole Genome Sequencing
11.4. PCR RT-PCR
12. Nucleic Acid Isolation & Purification Market, by End User
12.1. Academic & Research Institutes
12.2. Clinical Diagnostics Laboratories
12.3. Contract Research Organizations
12.4. Pharmaceutical & Biotechnology Companies
13. Nucleic Acid Isolation & Purification Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Nucleic Acid Isolation & Purification Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Nucleic Acid Isolation & Purification Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Agilent Technologies Inc.
16.3.2. Becton, Dickinson and Company
16.3.3. Bio-Rad Laboratories, Inc.
16.3.4. Merck KGaA
16.3.5. Perkin Elmer Inc.
16.3.6. Promega Corporation
16.3.7. Takara Bio Inc.
16.3.8. Thermo Fisher Scientific Inc.
16.3.9. Norgen Biotec Corp.
16.3.10. Genaxxon bioscience GmbH
16.3.11. Danaher Corporation
16.3.12. F. Hoffmann-La Roche Ltd.
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Nucleic Acid Isolation & Purification market report include:
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Perkin Elmer Inc.
  • Promega Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Norgen Biotec Corp.
  • Genaxxon bioscience GmbH
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.

Table Information